JPH0889265A - Production of triglyceride containing highly unsaturated fatty acid - Google Patents
Production of triglyceride containing highly unsaturated fatty acidInfo
- Publication number
- JPH0889265A JPH0889265A JP6235746A JP23574694A JPH0889265A JP H0889265 A JPH0889265 A JP H0889265A JP 6235746 A JP6235746 A JP 6235746A JP 23574694 A JP23574694 A JP 23574694A JP H0889265 A JPH0889265 A JP H0889265A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- lipase
- highly unsaturated
- reaction
- unsaturated fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 title claims abstract description 24
- 235000021122 unsaturated fatty acids Nutrition 0.000 title abstract description 17
- 150000004670 unsaturated fatty acids Chemical class 0.000 title abstract description 17
- 238000004519 manufacturing process Methods 0.000 title description 11
- 239000004367 Lipase Substances 0.000 claims abstract description 46
- 102000004882 Lipase Human genes 0.000 claims abstract description 46
- 108090001060 Lipase Proteins 0.000 claims abstract description 46
- 235000019421 lipase Nutrition 0.000 claims abstract description 46
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 claims abstract description 24
- 235000020669 docosahexaenoic acid Nutrition 0.000 claims abstract description 21
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 20
- 229930195729 fatty acid Natural products 0.000 claims abstract description 20
- 239000000194 fatty acid Substances 0.000 claims abstract description 20
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 20
- 235000020673 eicosapentaenoic acid Nutrition 0.000 claims abstract description 16
- 239000000470 constituent Substances 0.000 claims abstract description 15
- 241000589774 Pseudomonas sp. Species 0.000 claims abstract description 5
- 241000222120 Candida <Saccharomycetales> Species 0.000 claims abstract description 4
- 241000146387 Chromobacterium viscosum Species 0.000 claims abstract description 4
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 claims abstract description 3
- 229940090949 docosahexaenoic acid Drugs 0.000 claims abstract description 3
- 229960005135 eicosapentaenoic acid Drugs 0.000 claims abstract description 3
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 claims abstract description 3
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 13
- 241000235527 Rhizopus Species 0.000 claims description 7
- 235000009508 confectionery Nutrition 0.000 claims description 7
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 abstract description 12
- 150000003626 triacylglycerols Chemical class 0.000 abstract description 5
- 230000002265 prevention Effects 0.000 abstract description 2
- 241000453701 Galactomyces candidum Species 0.000 abstract 1
- 235000017388 Geotrichum candidum Nutrition 0.000 abstract 1
- 241000303962 Rhizopus delemar Species 0.000 abstract 1
- 208000015122 neurodegenerative disease Diseases 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 30
- 238000006243 chemical reaction Methods 0.000 description 25
- 239000003921 oil Substances 0.000 description 15
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 14
- 235000011187 glycerol Nutrition 0.000 description 13
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 12
- 239000003925 fat Substances 0.000 description 11
- 235000019197 fats Nutrition 0.000 description 11
- 238000006911 enzymatic reaction Methods 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 7
- 239000000741 silica gel Substances 0.000 description 7
- 229910002027 silica gel Inorganic materials 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 239000008213 purified water Substances 0.000 description 5
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000000758 substrate Substances 0.000 description 3
- 238000005809 transesterification reaction Methods 0.000 description 3
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000588881 Chromobacterium Species 0.000 description 2
- 241000159512 Geotrichum Species 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- 230000000489 anti-atherogenic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 150000005690 diesters Chemical class 0.000 description 2
- IJKVHSBPTUYDLN-UHFFFAOYSA-N dihydroxy(oxo)silane Chemical compound O[Si](O)=O IJKVHSBPTUYDLN-UHFFFAOYSA-N 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- ITNKVODZACVXDS-YNUSHXQLSA-N ethyl (4Z,7Z,10Z,13Z,16Z,19Z)-docosahexaenoate Chemical compound CCOC(=O)CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC ITNKVODZACVXDS-YNUSHXQLSA-N 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 235000021588 free fatty acids Nutrition 0.000 description 2
- -1 glycerin ester Chemical class 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 238000006460 hydrolysis reaction Methods 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 238000004809 thin layer chromatography Methods 0.000 description 2
- 150000005691 triesters Chemical class 0.000 description 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 229920000064 Ethyl eicosapentaenoic acid Polymers 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000006173 Good's buffer Substances 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 102000004157 Hydrolases Human genes 0.000 description 1
- 108090000604 Hydrolases Proteins 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000008351 acetate buffer Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- RTEXIPZMMDUXMR-UHFFFAOYSA-N benzene;ethyl acetate Chemical compound CCOC(C)=O.C1=CC=CC=C1 RTEXIPZMMDUXMR-UHFFFAOYSA-N 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000010701 ester synthesis reaction Methods 0.000 description 1
- SSQPWTVBQMWLSZ-AAQCHOMXSA-N ethyl (5Z,8Z,11Z,14Z,17Z)-icosapentaenoate Chemical compound CCOC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CC SSQPWTVBQMWLSZ-AAQCHOMXSA-N 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 229940013317 fish oils Drugs 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 230000003308 immunostimulating effect Effects 0.000 description 1
- 239000011261 inert gas Substances 0.000 description 1
- 239000003456 ion exchange resin Substances 0.000 description 1
- 229920003303 ion-exchange polymer Polymers 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000000199 molecular distillation Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 238000004445 quantitative analysis Methods 0.000 description 1
- 235000003441 saturated fatty acids Nutrition 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 238000001256 steam distillation Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
Abstract
Description
【0001】[0001]
【産業上の利用分野】本発明は、酵素反応を用いて高度
不飽和脂肪酸含有トリグリセリドを製造する方法に関す
るものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a method for producing highly unsaturated fatty acid-containing triglyceride using an enzymatic reaction.
【0002】[0002]
【従来の技術】ω3系高度不飽和脂肪酸を含有する油脂
は、トリグリセリドの形態で魚油等に多く含まれる。ω
3系高度不飽和脂肪酸の中でドコサヘキサエン酸(以
下、DHAと略す。)は、学習機能改善作用、抗動脈硬
化作用、抗腫瘍作用、免疫賦活作用、抗アレルギー作用
等を有し、エイコサペンタエン酸(以下、EPAと略
す。)は、抗動脈硬化作用、抗腫瘍作用等の有用な生理
活性を有することが知られている。天然に存在する油脂
には、構成脂肪酸として、DHAやEPAが多くても2
0〜30%程度含まれるが、この他に多量のパルミチン
酸やステアリン酸等の飽和脂肪酸やリノール酸に代表さ
れるω6系高度不飽和脂肪酸が含まれている。そのため
に、このような天然油脂を健康食品や医薬品として使用
する際に、脂質過多という不都合が生じていた。この不
都合を解消するために、DHA以外の脂肪酸を低減した
油脂が酵素法によって調製された(Yukihisa
Tanaka et al.,Journal of
American Oil Chemical Soc
iety, 69,(1992),1210−121
4)。また、遊離の高純度DHAとグリセリンとを原料
として用いたリパーゼによるエステル合成反応や、高純
度DHAエチルエステルのリパーゼによるエステル交換
反応を利用して調製した高濃度DHA油脂に関する報告
がなされている(田中幸久等、油化学、41巻、199
2年、563−567頁および特開平5−331105
号公報)。2. Description of the Related Art Oils and fats containing ω3 polyunsaturated fatty acids are often contained in fish oils in the form of triglycerides. ω
Docosahexaenoic acid (hereinafter abbreviated as DHA) is a type 3 polyunsaturated fatty acid, which has a learning function improving action, an anti-atherogenic action, an antitumor action, an immunostimulating action, an antiallergic action, and the like, and eicosapentaenoic acid. (Hereinafter, abbreviated as EPA) is known to have useful physiological activities such as anti-atherogenic effect and anti-tumor effect. Naturally occurring fats and oils have at most 2 as constituent fatty acids, DHA and EPA.
The content is about 0 to 30%, but in addition to this, a large amount of saturated fatty acids such as palmitic acid and stearic acid, and highly unsaturated ω6 fatty acids represented by linoleic acid are contained. Therefore, when such natural fats and oils are used as health foods and pharmaceuticals, there has been a problem of excess lipid. In order to eliminate this inconvenience, fats and oils reduced in fatty acids other than DHA were prepared by an enzymatic method (Yukihisa).
Tanaka et al. , Journal of
American Oil Chemical Soc
iety, 69, (1992), 1210-121.
4). Further, there has been reported a high-concentration DHA oil and fat prepared by utilizing an ester synthesis reaction by lipase using free high-purity DHA and glycerin as raw materials and a transesterification reaction of high-purity DHA ethyl ester by lipase ( Yukihisa Tanaka et al., Oil Chemistry, Volume 41, 199.
2 years, pp. 563-567 and JP-A-5-331105.
Issue).
【0003】[0003]
【発明が解決しようとする課題】前記のYukihis
a Tanaka et al.,Journal o
f American Oil Chemical S
ociety, 69,(1992),1210−12
14に記されている方法は、油脂を構成している脂肪酸
に対するリパーゼの加水分解特異性の差を利用して、D
HA濃度を50%程度に上げるものであるが、DHAの
濃縮度の点で不十分であった。また、田中幸久等、油化
学、41巻、1992年、563−567頁および特開
平5−331105号公報に記載されている方法は、極
端に低い水濃度環境下でDHAの遊離型の脂肪酸とグリ
セリンとを反応させてエステルを合成するものである
が、反応系内の水分濃度の厳密なコントロールが必須で
あった。また、この反応に使用する原料のDHAの遊離
酸は空気酸化に対する安定性がグリセリンエステルより
も劣る等の欠点を有していた。従って、本発明は、かか
る従来技術の欠点を克服した、高度不飽和脂肪酸を高濃
度で含有する油脂(すなわち、トリグリセリド)を製造
する方法を提供することを目的とする。DISCLOSURE OF THE INVENTION Problems to be Solved by the Invention
a Tanaka et al. , Journal o
f American Oil Chemical S
ociety, 69, (1992), 1210-12.
The method described in 14 makes use of the difference in the hydrolysis specificity of lipase with respect to the fatty acids constituting fats and oils.
Although the HA concentration was raised to about 50%, it was insufficient in terms of DHA concentration. Further, the method described in Yukihisa Tanaka et al., Oil Chemistry, Vol. 41, 1992, p. Although the reaction is performed with glycerin to synthesize an ester, strict control of the water concentration in the reaction system is essential. Further, the free acid of DHA, which is a raw material used in this reaction, has a drawback that the stability against air oxidation is inferior to that of glycerin ester. Therefore, it is an object of the present invention to provide a method for producing an oil or fat (ie, triglyceride) containing a high concentration of highly unsaturated fatty acid, which overcomes the drawbacks of the conventional techniques.
【0004】[0004]
【課題を解決するための手段】本発明者らは、鋭意研究
を行った結果、リパーゼの酵素反応を利用して、高度不
飽和脂肪酸を構成脂肪酸とするモノおよび/またはジグ
リセリドから高度不飽和脂肪酸含有トリグリセリドを製
造する方法を見い出し、本発明を完成するに至った。Means for Solving the Problems As a result of intensive studies, the present inventors have utilized the enzymatic reaction of lipase to convert highly unsaturated fatty acids from mono- and / or diglycerides into highly unsaturated fatty acids. The inventors have found a method for producing contained triglycerides and completed the present invention.
【0005】すなわち、本発明は、高度不飽和脂肪酸を
構成脂肪酸とするモノおよび/またはジグリセリドにリ
パーゼを作用させることを特徴とする、高度不飽和脂肪
酸含有トリグリセリドの製造方法を提供する。本発明の
製造方法においては、高度不飽和脂肪酸を構成脂肪酸と
するモノおよび/またはジグリセリドを基質にして、リ
パーゼによる加水分解反応と同時に高度不飽和脂肪酸の
エステル交換(合成)反応が進行して、高度不飽和脂肪
酸を構成脂肪酸とするトリグリセリドが生成される。That is, the present invention provides a method for producing a highly unsaturated fatty acid-containing triglyceride, which comprises allowing a lipase to act on a mono- and / or diglyceride having a polyunsaturated fatty acid as a constituent fatty acid. In the production method of the present invention, using a mono- and / or diglyceride having a polyunsaturated fatty acid as a constituent fatty acid as a substrate, a hydrolysis reaction with lipase and a transesterification (synthesis) reaction of the polyunsaturated fatty acid simultaneously proceed, Triglycerides containing highly unsaturated fatty acids as constituent fatty acids are produced.
【0006】以下本発明を詳細に説明する。本明細書に
おいて、「高度不飽和脂肪酸を構成脂肪酸とするモノお
よび/またはジグリセリド」は、グリセロールと高度不
飽和脂肪酸とのモノエステル、グリセロールと高度不飽
和脂肪酸とのジエステル、およびグリセロールと高度不
飽和脂肪酸および他の脂肪酸とのジエステルを含むもの
とする。The present invention will be described in detail below. In the present specification, “mono- and / or diglyceride having polyunsaturated fatty acid as a constituent fatty acid” means a monoester of glycerol and highly unsaturated fatty acid, a diester of glycerol and highly unsaturated fatty acid, and glycerol and highly unsaturated. It is intended to include fatty acids and diesters with other fatty acids.
【0007】本発明で用いられる「高度不飽和脂肪酸を
構成脂肪酸とするモノおよび/またはジグリセリド」と
しては、グリセリンと高度不飽和脂肪酸との化学的な合
成反応や、グリセリンと高度不飽和脂肪酸を用いたリパ
ーゼによる合成反応により得られるものの他、高度不飽
和脂肪酸を含有するリン脂質にリン脂質加水分解酵素の
ホスフォリパーゼCを作用させることによって得られる
ものを使用することができ、これらは、モノグリセリ
ド、ジグリセリド単独でもこれらの混合物であっても良
い。高度不飽和脂肪酸を構成脂肪酸とするモノおよび/
またはジグリセリドとしては、特に有用な生理活性を有
するDHAおよび/またはEPAを構成脂肪酸とするモ
ノおよび/またはジグリセリドが好ましい。As the "mono- and / or diglyceride having a polyunsaturated fatty acid as a constituent fatty acid" used in the present invention, a chemical synthetic reaction between glycerin and a polyunsaturated fatty acid, glycerin and a polyunsaturated fatty acid are used. In addition to those obtained by a synthetic reaction with lipase, the one obtained by reacting phospholipid C, which is a phospholipid hydrolase, with a phospholipid containing a polyunsaturated fatty acid can be used. , Diglyceride alone or a mixture thereof. Mono- and / or polyunsaturated fatty acids as constituent fatty acids
Alternatively, the diglyceride is preferably a mono- and / or diglyceride having DHA and / or EPA as constituent fatty acids, which have particularly useful physiological activity.
【0008】本発明で用いられるリパーゼは、特にその
起源を問わず使用することができるが、供給面で安定し
ている微生物由来の酵素、例えばキャンディダ(Can
dida)属、ゲオトリカム(Geotrichum)
属等の酵母由来のリパーゼ、クロモバクテリウム(Ch
romobacterium)属、シュードモナス(P
seudomonas)属等の細菌由来のリパーゼ、リ
ゾプス(Rhizopus)属等の糸状菌由来のリパー
ゼが好ましく、ゲオトリカム・キャンディダム(Geo
trichum candidum)由来のリパーゼ、
キャンディダ・シリンドラシェ(Candida cy
lindracea)由来のリパーゼ、クロモバクテリ
ウム・ビスコサム(Chromobacterium
viscosum)由来のリパーゼ、シュードモナス・
エスピー(Pseudomonas sp.)由来のリ
パーゼ、およびリゾプス・デレマー(Rhizopus
delemer)由来のリパーゼがより好ましい。上記
の酵素は単独であるいは組み合わせて使用することがで
きる。The lipase used in the present invention can be used irrespective of its origin, but an enzyme derived from a microorganism which is stable in terms of supply, for example, Candida (Can
genus Dida), Geotrichum
Yeast-derived lipases such as genus Chromobacterium (Ch
genus Rhomobacterium, Pseudomonas (P
A lipase derived from a bacterium such as the genus Seudomonas and a lipase derived from a filamentous fungus such as the genus Rhizopus are preferable, and Geotricum candy dam (Geo)
trichum candidum) -derived lipase,
Candida cyrus
lipase derived from Chromobacteria (Chromobacteria)
viscosum) -derived lipase, Pseudomonas
Lipase derived from Pseudomonas sp., And Rhizopus
More preferred is a lipase derived from (delemer). The above enzymes can be used alone or in combination.
【0009】リパーゼによる酵素反応は、酵素の活性を
発現するのに十分の量の水の存在下で行えばよいが、そ
の量は、例えば、原料である高度不飽和脂肪酸を構成脂
肪酸とするモノおよび/またはジグリセリドに対して1
0〜4000重量%であり、好ましくは50〜2000
重量%程度である。酵素反応のpHを一定に保つため
に、水の代わりに、酢酸緩衝液、燐酸緩衝液、グッドの
緩衝液等の緩衝液を用いてもよい。反応のpHは、用い
る酵素が失活しない範囲で選択すればよいが、好ましく
は、pH3.5〜7.5であり、より好ましくは、pH4〜
6である。更に酵素反応を速めるためにカルシウムやマ
グネシウム等の2価の陽イオン、アラビアゴムやポリビ
ニルアルコール等の分散剤などを反応液中に添加しても
よい。The enzyme reaction with lipase may be carried out in the presence of a sufficient amount of water for expressing the activity of the enzyme, and the amount thereof is, for example, a mono-unsaturated fatty acid as a constituent fatty acid. And / or 1 for diglyceride
0 to 4000% by weight, preferably 50 to 2000
It is about% by weight. In order to keep the pH of the enzyme reaction constant, a buffer solution such as an acetate buffer solution, a phosphate buffer solution, and Good's buffer solution may be used instead of water. The pH of the reaction may be selected within a range in which the enzyme used is not inactivated, but is preferably pH 3.5 to 7.5, and more preferably pH 4 to
It is 6. Further, in order to accelerate the enzymatic reaction, a divalent cation such as calcium or magnesium, a dispersant such as gum arabic or polyvinyl alcohol, or the like may be added to the reaction solution.
【0010】前記酵素の使用量は基質となる高度不飽和
脂肪酸を構成脂肪酸とするモノおよび/またはジグリセ
リドの濃度、反応温度、反応pH、反応時間によっても
変わるが、反応液1gあたり2〜10000ユニット
(U)が適当であり、好ましくは10〜1000ユニッ
ト(U)程度である。また、基質となる高度不飽和脂肪
酸を構成脂肪酸とするモノおよび/またはジグリセリド
の濃度は、5〜90%が適当であり、10〜50%が好
ましい。反応温度はリパーゼが失活しない範囲で適宜選
ぶことができるが、好ましくは20〜50℃である。The amount of the enzyme to be used varies depending on the concentration of mono- and / or diglyceride containing a highly unsaturated fatty acid as a substrate as a constituent fatty acid, the reaction temperature, the reaction pH, and the reaction time, but is 2 to 10,000 units per 1 g of the reaction solution. (U) is suitable, and preferably about 10 to 1000 units (U). Further, the concentration of mono- and / or diglyceride containing highly unsaturated fatty acid as a substrate as a constituent fatty acid is appropriately 5 to 90%, preferably 10 to 50%. The reaction temperature can be appropriately selected within the range where the lipase is not inactivated, but it is preferably 20 to 50 ° C.
【0011】酵素反応は空気存在下でも問題なく進行す
るが、一般的に高度不飽和脂肪酸は酸化されやすいので
窒素やアルゴンガス等の不活性ガスを用いて酸素を遮断
した環境下で反応を行うことが好ましい。The enzymatic reaction proceeds without problems even in the presence of air, but generally, polyunsaturated fatty acids are easily oxidized, so the reaction is carried out in an environment in which oxygen is blocked using an inert gas such as nitrogen or argon gas. It is preferable.
【0012】反応時間は、反応生成物量をシリカゲルプ
レートを用いた薄層クロマトやシリカゲルロッドを用い
た定量的な分析ができるイヤトロスキャンで分析しなが
ら適宜設定できるが、反応生成物量が最大となるように
設定することが好ましい。薄層クロマトを用いて反応生
成物量を分析する場合には、展開溶媒としてクロロホル
ム:アセトン:酢酸(96:4:1)を使用することが
でき、イヤトロスキャンを用いて反応生成物量を分析す
る場合には、展開溶媒としてベンゼン:クロロホルム:
酢酸(50:20:0.5)を使用することができる。The reaction time can be appropriately set while analyzing the amount of the reaction product by thin layer chromatography using a silica gel plate or by an ear tro scan capable of quantitative analysis using a silica gel rod, but the amount of the reaction product becomes maximum. It is preferable to set as follows. When the reaction product amount is analyzed using thin-layer chromatography, chloroform: acetone: acetic acid (96: 4: 1) can be used as a developing solvent, and the reaction product amount is analyzed using an earloscan. In some cases, benzene: chloroform:
Acetic acid (50: 20: 0.5) can be used.
【0013】反応後の主要な生成物は高度不飽和脂肪酸
含有トリグリセリドであるが、一部遊離の脂肪酸やモノ
および/またはジグリセリドが混入する場合がある。こ
の場合には、通常行われているアルカリ脱酸法、分子蒸
留法、水蒸気蒸留法、膜分離法、イオン交換樹脂や各種
の吸着担体を用いた吸着クロマトによる分画等の手段を
利用して、これらの副生成物や原料を分離すればよく、
特にその方法は問わない。The main product after the reaction is a highly unsaturated fatty acid-containing triglyceride, but some free fatty acids and mono- and / or diglycerides may be mixed in. In this case, a commonly used means such as an alkali deoxidation method, a molecular distillation method, a steam distillation method, a membrane separation method, a fractionation by adsorption chromatography using an ion exchange resin or various adsorption carriers is used. , It suffices to separate these by-products and raw materials,
The method is not particularly limited.
【0014】上記のようにして得られる高度不飽和脂肪
酸含有トリグリセリドは、高度不飽和脂肪酸を高濃度で
含むトリグリセリドであるが、これには、グリセロール
と高度不飽和脂肪酸とのトリエステル、およびグリセロ
ールと高度不飽和脂肪酸および他の脂肪酸とのトリエス
テルが含まれる。The polyglyceride containing a polyunsaturated fatty acid obtained as described above is a triglyceride containing a high concentration of a polyunsaturated fatty acid, which includes a triester of glycerol and a polyunsaturated fatty acid, and glycerol. Includes polyunsaturated fatty acids and triesters with other fatty acids.
【0015】[0015]
【発明の効果】本発明の方法によれば、リパーゼを用い
て、高度不飽和脂肪酸を構成脂肪酸とするモノおよび/
またはジグリセリドからEPAやDHA等の有用な高度
不飽和脂肪酸を高濃度に含有するトリグリセリドを効率
良く製造することができる。この高度不飽和脂肪酸を高
濃度に含有するトリグリセリドは成人病の予防や治療に
用いることができる。INDUSTRIAL APPLICABILITY According to the method of the present invention, lipase is used to produce mono- and / or polyunsaturated fatty acids as constituent fatty acids.
Alternatively, triglycerides containing useful highly unsaturated fatty acids such as EPA and DHA at high concentrations can be efficiently produced from diglycerides. The triglyceride containing a high concentration of this polyunsaturated fatty acid can be used for prevention and treatment of adult diseases.
【0016】[0016]
【実施例】以下に、実施例を挙げて本発明を更に詳細に
説明するが、本発明はこれにより何ら限定されるもので
ない。The present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
【0017】 〔参考例1〕モノグリセリド、ジグリセリドの合成 モノグリセリドは、グリセリン20gと水酸化ナトリウ
ム50mgを60mlのジメチルホルムアミドの溶解し
た後、この溶液にDHAのエチルエステル(マルハ株式
会社製)とEPAのエチルエステル(マルハ株式会社
製)をそれぞれ7gずつ添加し、70℃で5時間攪拌し
ながらエステル交換反応を行うことにより調製した。反
応後、n−ヘキサン抽出を行い、この抽出物をシリカゲ
ル60のカラム(3×25cm、メルク社シリカゲル6
0を充填)にかけ、未反応のエチルエステルとジグリセ
リドとをベンゼン:酢酸エチル(8:2)で溶出除去し
た後、ベンゼン;酢酸エチル(6:4)でモノグリセリ
ドを溶出させた。DHAのモノグリセリドが5.8g、
EPAのモノグリセリドが6.7g得られた。[Reference Example 1] Synthesis of monoglyceride and diglyceride Monoglyceride was prepared by dissolving 20 g of glycerin and 50 mg of sodium hydroxide in 60 ml of dimethylformamide, and then dissolving DHA ethyl ester (Maruha Co., Ltd.) and EPA ethyl ester in this solution. 7 g of each ester (manufactured by Maruha Co., Ltd.) was added, and transesterification was performed while stirring at 70 ° C. for 5 hours. After the reaction, extraction with n-hexane was performed, and this extract was subjected to a silica gel 60 column (3 × 25 cm, silica gel 6 manufactured by Merck & Co., Inc.).
0) and unreacted ethyl ester and diglyceride were eluted and removed with benzene: ethyl acetate (8: 2), and then monoglyceride was eluted with benzene; ethyl acetate (6: 4). DHA monoglyceride 5.8g,
6.7 g of EPA monoglyceride was obtained.
【0018】ジグリセリドはグリセリンと遊離の脂肪酸
とから酵素法により合成した。すなわち、4.6gのグ
リセリン、16gのDHA(マルハ株式会社製)、およ
び16gのEPA(マルハ株式会社製)を混合し、次い
で2500単位のクロモバクテリウム由来のリパーゼ
(旭化成工業株式会社製、商品名 LPT-01 )を含む0.
5mlの水溶液を添加し、50℃で70時間攪拌しなが
ら反応を行った。反応後、n−ヘキサンで抽出したグリ
セリド画分をシリカゲルカラム(3×25cm、メルク
社シリカゲル60を充填)にかけ、トリグリセリド画分
をベンゼンで溶出し、次いでベンゼン:酢酸エチル
(9:1)でジグリセリドを溶出させた。DHAのジグ
リセリドが1.4g、EPAのジグリセリドが1.3g
得られた。Diglyceride was synthesized from glycerin and free fatty acid by an enzymatic method. That is, 4.6 g of glycerin, 16 g of DHA (manufactured by Maruha Co., Ltd.), and 16 g of EPA (manufactured by Maruha Co., Ltd.) were mixed, and then 2500 units of lipase derived from Chromobacterium (manufactured by Asahi Kasei Kogyo Co., Ltd., product Including the name LPT-01).
5 ml of an aqueous solution was added, and the reaction was carried out while stirring at 50 ° C. for 70 hours. After the reaction, the glyceride fraction extracted with n-hexane was applied to a silica gel column (3 × 25 cm, packed with Merck silica gel 60), the triglyceride fraction was eluted with benzene, and then diglyceride was added with benzene: ethyl acetate (9: 1). Was eluted. 1.4 g of DHA diglyceride and 1.3 g of EPA diglyceride
Obtained.
【0019】 〔実施例1〕モノグリセリドからトリグリセリドの製造 参考例1で製造したDHAモノグリセリド2gを2ml
の精製水に懸濁し、これにゲオトリカム・キャンディダ
ム(ゲオトリカム・キャンディダムATCC34614
株)から得た200単位のリパーゼを加え、30℃で攪
拌しながら20時間反応を行った。反応液のpHは特に
調整しなかったが、pHは4.9付近で推移した。反応
後、100mlのn−ヘキサンで油脂の抽出を行い、こ
れから参考例1に記載したシリカゲルカラム条件でトリ
グリセリドを溶出させ、1.3gのDHAトリグリセリ
ドを得た。Example 1 Production of Triglyceride from Monoglyceride 2 ml of 2 g of DHA monoglyceride produced in Reference Example 1
Suspended in purified water of Geotricum candy dam (Geotricum candy dam ATCC 34614
(200 strains of lipase) was added, and the reaction was carried out at 30 ° C. for 20 hours with stirring. The pH of the reaction solution was not particularly adjusted, but the pH remained around 4.9. After the reaction, oil and fat was extracted with 100 ml of n-hexane, and triglyceride was eluted under the silica gel column conditions described in Reference Example 1 to obtain 1.3 g of DHA triglyceride.
【0020】 〔実施例2〕モノグリセリドからトリグリセリドの製造 参考例1で製造したEPAモノグリセリド2gを2ml
の精製水に懸濁し、これにゲオトリカム・キャンディダ
ム(ゲオトリカム・キャンディダムATCC34614
株)から得た200単位のリパーゼを加え、30℃で攪
拌しながら16時間反応を行った。反応後、100ml
のn−ヘキサンで油脂の抽出を行い、これから参考例1
に記載したシリカゲルカラム条件でトリグリセリドを溶
出させ、0.9gのEPAトリグリセリドを得た。Example 2 Production of Triglyceride from Monoglyceride 2 ml of 2 g of EPA monoglyceride produced in Reference Example 1
Suspended in purified water of Geotricum candy dam (Geotricum candy dam ATCC 34614
200 units of lipase obtained from K.K.) was added, and the reaction was carried out for 16 hours while stirring at 30 ° C. 100 ml after reaction
Extraction of fats and oils with n-hexane from Example 1
The triglyceride was eluted under the silica gel column conditions described in 1. to obtain 0.9 g of EPA triglyceride.
【0021】 〔実施例3〕ジグリセリドからトリグリセリドの製造 参考例1で製造したDHAジグリセリド、EPAジグリ
セリド各1gを3mlの精製水に懸濁し、ゲオトリカム
・キャンディダム(ゲオトリカム・キャンディダムAT
CC34614株)から得た200単位のリパーゼを加
え、30℃で16時間反応を行った。反応後、100m
lのn−ヘキサンで油脂の抽出を行い、これから参考例
1に記載したシリカゲルカラム条件でトリグリセリドを
溶出させ、710mgのDHAトリグリセリド、590
mgのEPAトリグリセリドを得た。[Example 3] Production of triglyceride from diglyceride 1 g of each of DHA diglyceride and EPA diglyceride produced in Reference Example 1 was suspended in 3 ml of purified water, and Geotricum candy dam (Geotricum candydam AT
200 units of lipase obtained from CC34614 strain) was added and reacted at 30 ° C. for 16 hours. 100m after reaction
The oil and fat was extracted with 1 n-hexane, and the triglyceride was eluted under the silica gel column conditions described in Reference Example 1 to obtain 710 mg of DHA triglyceride, 590
Obtained mg EPA triglyceride.
【0022】 〔実施例4〕モノグリセリドからトリグリセリドの製造 参考例1で製造したEPAモノグリセリド500mgを
精製水3.5mlに懸濁し、200単位の各種リパーゼ
(ゲオトリカム・キャンディダム由来のリパーゼはゲオ
トリカム・キャンディダムATCC34614株より、
リゾプス・デレマー由来のリパーゼはリゾプス・デレマ
ーATCC34612株より得たものであった。また、
クロモバクテリウム・ビスコサム由来のリパーゼは旭化
成工業株式会社製のLPT-01、シュードモナス・エスピー
由来のリパーゼは旭化成工業株式会社製のCENT-18 、キ
ャンディダ・シリンドラシェ由来のリパーゼはシグマ社
の市販酵素L-8525であった。)を添加し、30℃で16
時間攪拌しながら反応を行った。油脂をn−ヘキサンで
抽出後、参考例1に記載の方法により精製EPAトリグ
リセリドを得た。結果を表1に示す。Example 4 Production of Triglyceride from Monoglyceride 500 mg of EPA monoglyceride produced in Reference Example 1 was suspended in 3.5 ml of purified water, and 200 units of various lipases (the lipase derived from Geotricum candydam was Geotricum candydam). From ATCC 34614 strain,
The lipase derived from Rhizopus duller was obtained from Rhizopus duller ATCC34612 strain. Also,
The lipase derived from Chromobacterium viscosum is LPT-01 manufactured by Asahi Kasei Kogyo Co., Ltd., the lipase derived from Pseudomonas sp. Is CENT-18 manufactured by Asahi Kasei Kogyo Co., Ltd. It was -8525. ) Is added and 16 at 30 ° C.
The reaction was carried out with stirring for a time. After extracting the oil and fat with n-hexane, a purified EPA triglyceride was obtained by the method described in Reference Example 1. The results are shown in Table 1.
【0023】[0023]
【表1】 [Table 1]
【0024】 〔実施例5〕ジグリセリドからトリグリセリドの製造 参考例1で製造したDHAジグリセリド200mgを精
製水3.8mlに懸濁し、200単位の各種リパーゼ
(ゲオトリカム・キャンディダム由来のリパーゼはゲオ
トリカム・キャンディダムATCC34614株より、
リゾプス・デレマー由来のリパーゼはリゾプス・デレマ
ーATCC34612株より得たものであった。また、
クロモバクテリウム・ビスコサム由来のリパーゼは旭化
成工業株式会社製LPT-01、シュードモナス・エスピー由
来のリパーゼは旭化成工業株式会社製CENT-18 、キャン
ディダ・シリンドラシェ由来のリパーゼはシグマ社の市
販酵素L-8525であった。)を添加し、30℃で攪拌しな
がら反応を行った。油脂をn−ヘキサンで抽出後、参考
例1に記載の方法により精製DHAトリグリセリドを得
た。結果を表2に示す。Example 5 Production of Triglyceride from Diglyceride 200 mg of DHA diglyceride produced in Reference Example 1 was suspended in 3.8 ml of purified water, and 200 units of various lipases (the lipase derived from Geotricum candydam was Geotrichum candydam). From ATCC 34614 strain,
The lipase derived from Rhizopus duller was obtained from Rhizopus duller ATCC34612 strain. Also,
The lipase derived from Chromobacterium viscosum is LPT-01 manufactured by Asahi Kasei Kogyo Co., Ltd., the lipase derived from Pseudomonas sp. Met. ) Was added and the reaction was carried out at 30 ° C. with stirring. After extracting the oil and fat with n-hexane, a purified DHA triglyceride was obtained by the method described in Reference Example 1. Table 2 shows the results.
【0025】[0025]
【表2】 [Table 2]
───────────────────────────────────────────────────── フロントページの続き (72)発明者 杉原 耿雄 兵庫県伊丹市千僧六丁目87番地 (72)発明者 島田 裕司 大阪府堺市櫛屋町東四丁2番31号 (72)発明者 丸山 一輝 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 (72)発明者 椎名 智香子 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 (72)発明者 中山 秀 茨城県つくば市和台16番2 マルハ株式会 社中央研究所内 (72)発明者 今村 茂行 静岡県富士市鮫島2番地の1 旭化成工業 株式会社内 (72)発明者 清水 俊雄 静岡県富士市鮫島2番地の1 旭化成工業 株式会社内 ─────────────────────────────────────────────────── ─── Continuation of the front page (72) Inventor Tetsuo Sugihara 87-thousand Senjo, Itami City, Hyogo Prefecture (72) Inventor Yuji Shimada 2-32 Higashi 4-chome, Kushiya-cho, Sakai City, Osaka Prefecture (72) Ikki Maruyama Ibaraki 16-2 Wadai, Tsukuba, Japan Inside the Central Research Institute, Maruha Co., Ltd. (72) Inventor: Chikako Shiina, 16-2, Wadai, Tsukuba, Ibaraki, Central Research Laboratory, Maruha Co., Ltd. (72) Hide Nakayama, Wa, Tsukuba, Ibaraki No. 16-2 Central Research Institute of Maruha Co., Ltd. (72) Inventor Shigeyuki Imamura 1 at 2 Samejima, Fuji City, Shizuoka Prefecture Asahi Kasei Corporation (72) Inventor Toshio Shimizu 1 at 2 Shimajima, Fuji City, Shizuoka Asahi Kasei Industry Within the corporation
Claims (3)
ノおよび/またはジグリセリドにリパーゼを作用させる
ことを特徴とする、高度不飽和脂肪酸含有トリグリセリ
ドの製造方法。1. A process for producing a triglyceride containing a polyunsaturated fatty acid, which comprises reacting a mono- and / or diglyceride having a polyunsaturated fatty acid as a constituent fatty acid with a lipase.
ダム由来のリパーゼ、キャンディダ・シリンドラシェ由
来のリパーゼ、クロモバクテリウム・ビスコサム由来の
リパーゼ、シュードモナス・エスピー由来のリパーゼ、
およびリゾプス・デレマー由来のリパーゼからなる群か
ら選択される少なくとも1種である、請求項1記載の方
法。2. A lipase derived from Geotricham candy dam, a lipase derived from Candida syrindrache, a lipase derived from Chromobacterium viscosum, a lipase derived from Pseudomonas sp.,
The method according to claim 1, wherein the method is at least one selected from the group consisting of and lipase derived from Rhizopus dermer.
酸および/またはエイコサペンタエン酸である請求項1
または2記載の方法。3. The polyunsaturated fatty acid is docosahexaenoic acid and / or eicosapentaenoic acid.
Or the method described in 2.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6235746A JPH0889265A (en) | 1994-09-29 | 1994-09-29 | Production of triglyceride containing highly unsaturated fatty acid |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP6235746A JPH0889265A (en) | 1994-09-29 | 1994-09-29 | Production of triglyceride containing highly unsaturated fatty acid |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0889265A true JPH0889265A (en) | 1996-04-09 |
Family
ID=16990617
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP6235746A Withdrawn JPH0889265A (en) | 1994-09-29 | 1994-09-29 | Production of triglyceride containing highly unsaturated fatty acid |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0889265A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006077860A1 (en) * | 2005-01-19 | 2006-07-27 | The Nisshin Oillio Group, Ltd. | Process for production of purified lipase |
WO2022211017A1 (en) * | 2021-04-01 | 2022-10-06 | 花王株式会社 | Oil/fat composition |
-
1994
- 1994-09-29 JP JP6235746A patent/JPH0889265A/en not_active Withdrawn
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006077860A1 (en) * | 2005-01-19 | 2006-07-27 | The Nisshin Oillio Group, Ltd. | Process for production of purified lipase |
EP2186886A1 (en) * | 2005-01-19 | 2010-05-19 | The Nisshin Oillio Group, Ltd. | Process for production of purified lipase |
WO2022211017A1 (en) * | 2021-04-01 | 2022-10-06 | 花王株式会社 | Oil/fat composition |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6537787B1 (en) | Enzymatic methods for polyunsaturated fatty acid enrichment | |
EP0191217B1 (en) | Process for producing glycerides in the presence of lipases | |
KR100538480B1 (en) | Process for the prodcution of glycerides with lipases | |
Halldorsson et al. | Lipase selectivity toward fatty acids commonly found in fish oil | |
US20080269329A1 (en) | Process for Production of Microbial Fat/Oil Containing Discretional Amount of Diacylglycerol and Said Fat/Oil | |
KR20040030787A (en) | Process for producing fat comprising triglyceride contaninig highly unsaturated fatty acid | |
JPH0591888A (en) | Production of omega-9 highly unsaturated faitty acid and lipid containing the same | |
JP3995290B2 (en) | Method for producing omega-9 polyunsaturated fatty acid and lipid containing the same | |
EP1035211B1 (en) | PROCESS FOR PRODUCING ARACHIDONIC ACID-CONTAINING LIPID AND DIHOMO-gamma-LINOLENIC ACID-CONTAINING LIPID | |
JP3526632B2 (en) | Fats and oils containing highly unsaturated fatty acids | |
DE102005057832A1 (en) | Process for the enzymatic synthesis of triglycerides | |
JP3689443B2 (en) | Process for producing highly unsaturated fatty acid-containing glycerides | |
JPH08214892A (en) | Production of partial glyceride containing highly unsaturated fatty acid | |
JPH0889265A (en) | Production of triglyceride containing highly unsaturated fatty acid | |
JP4036595B2 (en) | Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same | |
JP4079494B2 (en) | Method for producing arachidonic acid and / or eicosapentaenoic acid-containing fats and oils | |
JP2707642B2 (en) | Method for producing lysophospholipid | |
JPH1175884A (en) | Production of highly unsaturated fatty acid-containing oil and fat | |
JPH062068B2 (en) | Method for producing ω6 unsaturated phospholipids containing unsaturated fatty acid | |
Carvalho et al. | Enrichment of gamma‐linolenic acid from fungal oil by lipases | |
JPH01137987A (en) | Production of highly unsaturated fatty acid glyceride | |
Aoki et al. | Production of eicosapentaenoic acid-enriched triacylglycerol by Mucor hiemalis HA-30 | |
JP4079978B2 (en) | Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same | |
JPH10323182A (en) | Culture solution of bacterium having phospholipase a1 activity, preparation of phospholipid highly containing docosahexaenoic acid and production of 2-acyllysophosphlipid | |
JPH0856683A (en) | Method for synthesizing lipid containing highly unsaturated fatty acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20020115 |